MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hrthm.2026.05.010

Медицинская библиотека · Heart rhythm · 2026

High-sensitivity cardiac troponin I for enhanced risk stratification in primary prevention for sudden cardiac death in hypertrophic cardiomyopathy.

Lai Zihao, Li Xiaofei, Fan Shuxin, Yan Hankun, Zhu Haojie, He Chen, Yao Yan, Fan Xiaohan

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Risk stratification of sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains challenging. High-sensitivity cardiac troponin I (hs-cTnI) specifically reflects myocardial damage whereas its relationship with SCD risk in HCM is unclear.

OBJECTIVE

This study aimed to investigate the prognostic value of hs-cTnI on enhancing SCD risk stratification in HCM.

METHODS

This cohort study consecutively enrolled 705 patients with confirmed diagnosis of HCM. The baseline and clinical follow-up data were collected. The primary end point was defined as SCD or SCD-equivalent events including witnessed arrhythmic cardiac arrest and sustained ventricular tachycardia or ventricular fibrillation requiring intervention.

RESULTS

The final analysis included 559 patients with a median age of 53.0 years, 66.2% male, 16.1% with an implantable cardioverter-defibrillator (ICD), and a median hs-cTnI level of 0.021 ng/mL. The mean follow-up was 862 days, with 51 patients (9.1%) experiencing SCD events. The hs-cTnI showed a significant nonlinear association with SCD risk and remained as an independent predictor (adjusted hazard ratio 2.93 [95% confidence interval 1.89‒4.54], P < .0001). The optimal threshold value of hs-cTnI for increased risk of SCD was 0.0405 ng/mL. The addition of hs-cTnI to the conventional risk score model significantly improved the predictive performance (C-statistic increased from 0.752 to 0.813; P = .007). Patients with both elevated risk score and hs-cTnI had the worst prognosis (P < .0001).

CONCLUSION

The hs-cTnI could be an independent predictor of SCD risk for patients with HCM. Integrating hs-cTnI into SCD risk assessment may provide additional indication of ICD implantation for primary prevention.

Для цитирования: Lai Zihao, Li Xiaofei, Fan Shuxin, Yan Hankun, Zhu Haojie, He Chen, Yao Yan, Fan Xiaohan. High-sensitivity cardiac troponin I for enhanced risk stratification in primary prevention for sudden cardiac death in hypertrophic cardiomyopathy.. Heart rhythm. 2026. DOI: 10.1016/j.hrthm.2026.05.010.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.